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Abstract 
Promiscuous galactokinases (GalKs), which catalyse the ATP dependent phosphorylation of 
galactose in nature, have been widely exploited in biotechnology for the rapid synthesis of diverse 
sugar-1-phosphates. This work focuses on the characterisation of a bacterial GalK from 
Streptomyces coelicolor (ScGalK), which was overproduced in Escherichia coli and shown to 
phosphorylate galactose. ScGalK displayed a broad substrate tolerance, with activity towards Gal, 
GalN, Gal3D, GalNAc, Man and L-Ara. Most interestingly, ScGalK demonstrated a high activity over 
a broad pH and temperature range, suggesting that the enzyme could be highly amenable to multi-
enzyme systems.  
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1. Introduction 
In nature, sugar phosphates have vital functions in physiological processes such as energy transfer 
and cell signalling, as well as being key constituents of nucleic acids [1, 2, 3, 4]. It is however, their 
roles in carbohydrate metabolism that have generated great interest in these compounds for 
pharmaceutical and biotechnological applications [5, 6, 7]. Sugar-1-phosphates in particular, are key 
intermediates in complex glycan biosynthesis, required for the formation of nucleotide-activated 
sugars [8].  
Galactose-1-phosphate (Gal-1P, 2) is an important intermediate in galactose (Gal, 1) metabolism, 
which ultimately results in the biosynthesis of uridine diphosphate galactose (UDP-Gal, 3). UDP-Gal 
(3) biosynthesis occurs by two major metabolic pathways, the salvage pathway and the Leloir 
pathway (Fig. 1) [9]. In the salvage pathway (A), a UDP-sugar pyrophosphorylase catalyses the 
conversion of Gal-1P (2) to UDP-Gal (3) in the presence of uridine triphosphate (UTP). In contrast, 
UDP-Gal (3) formation via the Leloir pathway (B) is catalysed by a galactose-1-phosphate 
uridyltransferase and UDP-glucose-4-epimerase. UDP-Gal (3) is then used as a substrate by 
galactosyltransferases, that facilitate the incorporation of galactose into diverse glycan structures.  
Various approaches exist for the synthesis of glycosyl phosphates (2). Chemical syntheses can be 
laborious, often requiring protecting group chemistry and can suffer from limited regio- and stereo-
control  [10, 11, 12, 13]. In contrast, enzymatic approaches often offer single-step syntheses, with 
high regio- and stereoselectivity, therefore eliminating the need for protecting group chemistry. 
Galactokinases (EC 2.7.1.6, GalKs), which catalyse the adenosine triphosphate (ATP) dependent 
phosphorylation of galactose in nature (Fig. 1), have been widely exploited in biotechnology for their 
ability to synthesise diverse sugar-1-phosphates for natural product diversification [14, 15]. GalKs 
belong to the GHMP family, that includes homoserine kinases, mevalonate kinases and 
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phosphomevalonate kinases [16]. While many eukaryotic GalKs have been characterised and 
studied for their role in type II galactosemia [17, 18, 19, 20, 21, 22, 23], it has been the 
characterisation of bacterial GalKs with their broad substrate preferences and high expression 
levels, that have really proven to be of great value in biotechnology [24, 25, 26, 27, 28]. In particular, 
GalKs have been widely exploited in multi enzyme systems for the chemo enzymatic synthesis of 
sugar nucleotides [29, 30] and ɴ1,3 galactosides [31, 32].  
Herein, we describe the cloning, overexpression and characterisation of the galactokinase from the 
soil bacterium, Streptomyces coelicolor. Investigation of its biochemical properties revealed the 
enzyme to maintain high activity over a broad pH and temperature range, suggesting that the 
enzyme could be highly amenable to one-pot multi enzyme systems. Additionally, studies of 
substrate specificity have revealed the enzyme to be active towards a range of unnatural substrates, 
demonstrating its potential for biotechnological exploitation. 
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Fig. 1 GalK mediated synthesis of Gal-1P (2) is an important precursor for UDP-Gal production via 
the salvage pathway (A) and the Leloir pathway (B). The SCO numbers for the proteins encoded in 
this pathway in S. coelicolor are shown. sco3136 (ScGalK) in S. coelicolor is found in the Leloir 
pathway operon that also encodes SCO3137 (GalE) and SCO3138 (GalT). Image to reproduced in 
colour on the Web (free of charge) and in black-and-white in print. 
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2. Results and Discussion: 
2.1 Cloning, over-expression and purification of ScGalK 
The GalK from S. coelicolor  (ScGalK) was previously investigated as a reporter for in vivo promoter 
strength [33], however the enzyme has never been heterologously expressed and its substrate 
specificity is currently unexplored. The gene encoding ScGalK in the S. coelicolor genome, sco3136, 
forms part of the Leloir pathway operon (Fig. 1), which also encodes a putative UDP-Gal 4-epimerase 
(SCO3137) and a galactose-1-phosphate uridyltransferase (SCO3138). An alignment of the ScGalK 
amino acid sequence with the sequences of previously characterised GalKs from Escherichia coli (E. 
coli, EcGalK), Lactococcus lactis (L. lactis, LlGalK), Streptococcus pneumoniae (S. pneumoniae, 
GalKSpe4), Leminorella grimontii (L. grimontii, LgGalK), Bifidobacterium infantis (B. infantis, BiGalK) 
and Meiothermus taiwanensis (M. taiwanensis, MtGalK) demonstrated that the three characteristic 
GHMP superfamily motifs were also conserved in ScGalK (Fig. S1) [34]. Additionally, ScGalK contains 
the two highly conserved catalytic amino acid residues, R30 and D191, that were previously 
demonstrated to be required for GalK function in L. lactis [35]. ScGalK was amplified by PCR from S. 
coelicolor A3(2) J1929 genomic DNA and cloned into pET15b with an N-ƚĞƌŵŝŶĂů,ŝƐA?-tag. ScGalK 
was overexpressed in E.coli BL21(DE3) under induction of 0.8 mM isopropyl ?1 ?thio ?ɴ ?D ?
galactopyranoside IPTG (16 °C for 22 h). The recombinant protein was purified by using a two-step 
purification procedure, first by Ni2+ affinity chromatography and then by gel filtration 
chromatography. A typical yield of active recombinant ScGalK was A? 33 mg/L of cell culture. The 
mobility of recombinant ScGalK by SDS-PAGE was consistent with the predicted molecular mass of 
the protein of 43.1 kDa (Fig. 2). 
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Fig. 2 SDS-PAGE analysis of ScGalK. Lanes: (M) protein Mw standard, (1) Total soluble, (2) Flow 
through, (3) Elution Ni2+ affinity chromatography, (4) Elution - size exclusion chromatography 
 
2.2 Biochemical characterisation of ScGalK 
To determine the biochemical properties of ScGalK, the effects of temperature, pH and metal ions 
were investigated on the activity of the enzyme for its natural substrate, Gal (1) (Fig. 3). The 
optimum temperature was found to be at 45 °C, with activity rapidly decreasing at higher 
temperatures (Fig. 3A). Interestingly, ScGalK appeared to retain a relatively high activity at lower 
temperatures, displaying A? 60% activity at 4 °C. In contrast to many of the previously characterised 
bacterial GalKs that display significant decreases in activity at lower temperatures, including 
GalKSpe4 (A? 45% activity at 25 °C), LgGalK (A? 40% activity at 4 °C) and BiGalK (A? 15% activity at 4 °C), 
this is quite an unusual characteristic [25, 26, 27]. ScGalK also sustains its activity over a wide pH 
range, with > 80% activity observed in the pH range 4  W 10 (Fig. 3B). This feature is most similar to 
GalKSpe4, which also maintains > 80% activity over the same pH range [25]. In contrast, maximal 
activity was observed only in the pH ranges 7.5  W 9 for BiGalK and 8  W 10 in LgGalK [26, 27]. 
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As observed in all previously characterised bacterial GalKs to date [24, 25, 26, 27, 28], ScGalK was 
shown to require DŐ ?A? as a cofactor (Fig. 3C). Amongst the bivalent ŵĞƚĂůĐĂƚŝŽŶƐƚĞƐƚĞĚ ?Ŷ ?A? could 
partially ƐƵďƐƚŝƚƵƚĞĨŽƌDŐ ?A?. In contrast, ScGalK activity was nearly eliminated in the presence of 
Ă ?A? ?Mn ?A? ĂŶĚƵ ?A? ? 
The kinetic parameters of ScGalK towards Gal (1) and ATP were determined by coupling the 
formation of adenosine diphosphate (ADP) to the reactions catalysed by pyruvate kinase and lactate 
dehydrogenase [36] (Table 1). Reactions were carried out under saturating concentrations of ATP 
(10 mM) with different concentrations of Gal (1), and with different concentrations of ATP under 
saturating conditions of Gal (1) respectively. The initial velocity was determined from the gradient 
of the linear phase of the reaction progress curve, and Michaelis-Menten plots were generated to 
obtain the apparent kinetic parameters for each substrate (Fig. S2). The Km values of ScGalK towards 
Gal (1) (0.627 mM) were comparable to those of BiGalK (0.895 mM), EcGalK (2.1 mM) and LgGalK 
(1.3 mM), however the enzyme displayed a significantly higher affinity for Gal (1) than GalKSpe4 
(37.23 mM) [24, 25, 26, 27]. The catalytic efficiency of the enzyme for Gal (1) (2.15 s¯¹ mM ¯¹) was 
higher than with GalKSpe4 (0.07 s¯¹ mM ¯¹) and EcGalK (0.552 s¯¹ mM ¯¹) [24, 25]. In contrast, higher 
catalytic efficiencies towards Gal (1) have been observed previously by BiGalK (164 s¯¹ mM ¯¹) and 
LgGalK (18.1 s¯¹ mM ¯¹) [26, 27]. Overall, the kinetic parameters of ScGalK show that the enzyme 
bears similarity to EcGalK.  
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Fig. 3 Physicochemical properties of ScGalK. (A) Temperature-activity profile. (B) pH- activity profile. 
(C) Metal ion dependence. Data represent the mean of three replicates. Error bars represent the 
standard error of the mean. Image to be reproduced in colour on the Web (free of charge) and in 
black-and-white in print. 
 
Table 1. Kinetic parameters for ScGalK 
Substrate Km (mM) kcat (s¯¹) kcat/Km (s¯¹ mM ¯¹) 
Gal 0.627 ± 0.061 1.350 ± 0.044 2.15 
ATP 0.035 ± 0.004 1.350 ± 0.033 38.90 
 
 
2.3 Determination of ScGalK substrate specificity 
In the initial studies of ScGalK substrate specificity, reactions were screened by TLC (Figure S3) and 
the presence of the glycosyl-1-phosphate products were validated by high resolution mass 
spectrometry (HRMS). The conversions of the substrates identified as hits during the initial screens 
were then determined by using the dinitrosalicylic acid (DNS) assay (Table 2) [24]. As expected, 
ScGalK demonstrated a high specificity for its natural substrate Gal (1), enabling 91% conversion 
after 2 h under optimised conditions. To further probe the substrate specificity of ScGalK and its 
potential for use in biocatalysis, 11 different monosaccharide substrates were investigated (Table 
2). Reactions that were carried out with the unnatural substrates, were allowed to proceed for 24 h 
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and contained A? 4-fold more enzyme than the reactions with Gal (1). We anticipated that the 
increased reaction times and enzyme concentrations might help to identify substrates that, due to 
their reduced affinity or catalytic turnover by the enzyme, may not otherwise be observed as 
substrates. ScGalK was found to have some activity towards 8 out of the 11 unnatural substrates 
that were tested  W mannose (6), mannosamine (7), N-acetyl-D-glucosamine (8), N-acetyl-D-
galactosamine (10), galactosamine (11), glucose (14), L-arabinose (15) and 3-deoxy-galactose (16). 
As shown in Table 2, the galactose derivatives 10 and 11 were observed as substrates for the 
enzyme, displaying conversions of 40% and 87% respectively. The lower conversion of 10 by 
comparison to 11 is consistent with previous observations that GalKs can tolerate small 
modifications to the C-2 position, however groups with increased steric bulk result in little or no 
substrate specificity [24, 25, 26, 27, 28]. ScGalK displayed high specificity towards 16, suggesting 
that the removal of the C-3 hydroxyl was well tolerated by the enzyme. Gluco-configured substrates 
were not well tolerated by the enzyme. This is consistent with observations made previously in other 
bacterial GalKs [24, 26, 27, 28]. Interestingly, ScGalK did show some activity towards D-mannose (6). 
The only previous report of galactokinase activity towards mannose was in the human galactokinase 
(GalK1) Y379C and Y379W mutants [37]. Timson and Kristiansson demonstrated that mutagenesis 
of residue Y379 in GalK1 resulted in an enzyme with broadened substrate specificity. While the Y379 
residue is not located within the GalK1 active site, amino acid changes at this position were shown 
to increase the overall flexibility of the enzyme. Interestingly, alterations to the equivalent residues 
in EcGalK (Y371) and LlGalK (Y385) have also been shown to increase enzyme substrate specificity 
[5, 6, 38]. Based on the amino acid sequence alignment of the characterised bacterial GalKs (Fig. 
S1), a conserved tyrosine residue that aligns with Y371 in EcGalK and Y385 in LlGalK, was observed 
in LgGalK and GalKSpe4. In contrast, ScGalK appears to lack a tyrosine at this position, which might 
contribute towards the broad substrate range of the enzyme. Interestingly, ScGalK also 
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demonstrated some low-level activity towards L-arabinose (15), which has only ever been reported 
in the wild-type GalK from Phaseolus aureus [39].  
The broad substrate tolerance of ScGalK, as well as the fact that the enzyme maintains high-level 
activity over a wide pH and temperature range (Fig. 3), suggests that the enzyme could be used in 
one-pot multi enzyme cascades for the chemo enzymatic synthesis of carbohydrates. For example, 
the unique activity of ScGalK towards L-arabinose could be exploited for the synthesis of UDP-L-
arabinose, by coupling the enzyme with the UDP-sugar pyrophosphorylase from Pisum sativum L., 
that was previously shown to use L-arabinose-1-phosphate as a substrate [40]. Additionally, the 
activity of ScGalK towards mannose suggests that the enzyme could be utilised as an alternative to 
an N-acetylhexosamine-1-kinase (NahK), in the one-pot multi enzyme synthesis of guanosine 
diphosphate (GDP) and uridine diphophosphate (UDP) mannose, in reactions coupled with GDP- 
and UDP-sugar pyrophosphorylases and inorganic pyrophosphatases [29, 41].  
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Table 2. Substrate specificity of ScGalK towards a panel of monosaccharides 
Substrate HRMS(a) TLC(a) Conv. (%) Substrate HRMS(a) TLC(a) Conv. (%) 
 
+ + 91 
 
+ + 87 
 
+ + 21 
 
- - n.d. 
 
+ - n.d. 
 
- - n.d. 
 
+ + < 5  
 
+ - 6 
 
- - n.d. 
 
+ + 10 
 
+ + 40 
 
+ + 85 
 
 
(a)
 +: product observed, -: no product observed. n.d. : ʹ conversion not determined; HRMS = 
High resolution mass spectrometry; TLC = thin layer chromatography. 
 
2.4 Use of SCO3138 in a one-pot two enzyme synthesis of lacto-n-biose.   
To demonstrate the utility of ScGalK, the enzyme was used in a one-pot two enzyme system 
(Scheme 1) with the D-galactosyl-ɴ ? W3-N-acetyl-D-hexosamine phosphorylase from B. infantis 
(BiGalHexNAcP) for the synthesis of lacto-n-biose. BiGalHexNAcP catalyses the phosphorolysis of 
lacto-n-biose and galacto-n-biose, to produce Gal-1-P (2) and the corresponding N-acetyl-D-
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hexosamine. However, by coupling BiGalHexNAcP with GalKs in a one-pot system, it is possible to 
utilise the ĞŶǌǇŵĞ ?Ɛreverse reaction for the ƐǇŶƚŚĞƐŝƐ ŽĨ ɴ ?-3 galactosides [31, 32, 42]. 
BiGalHexNAcP has a relatively narrow pH range (5  W 6.5) under which it displays maximal activity 
[31]. Therefore, reactions were carried out at pH 6.5 to ascertain that both ScGalK and 
BiGalHexNAcP displayed high activity. For the synthesis of lacto-n-biose (17), reactions were 
assembled on a 50 mg scale with Gal (1), GlcNAc (8), ScGalK and BiGalHexNAcP in the presence of 
DŐ ?A?ĂŶĚdW ?ĨƚĞƌƉƌŽĐĞĞĚŝŶŐĨŽƌ ? ?Ś ?ƚŚĞƌĞĂĐƚŝŽŶƉƌŽĚƵĐƚƐǁĞƌĞƉƵƌŝĨŝĞĚďǇĂŶŝŽŶĞǆĐŚĂŶŐĞ
and then gel filtration chromatography, and the synthesis of lacto-n-biose (17) was validated by 
NMR (Figure S4-8). Lacto-n-biose was isolated in a moderate yield of 68%, which is lower than the 
95% yield previously reported by Xi Chen and co-workers using the EcGalK/BiGalHexNAcP coupled 
system [31]. However, as the reaction appeared to proceed to completion (Fig. S10), the lower yield 
could be explained by the smaller reaction scale and differences in purification methodologies. 
 
 
Scheme 1: One-pot two enzyme synthesis of lacto-n-biose (4) catalysed by ScGalK and 
BiGalHexNAcP. 
 
 
 
 
 
3. Conclusions 
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We have characterised and overexpressed a new bacterial galactokinase (SCO3138) from 
Streptomyces coelicolor. We have investigated the effects of temperature, pH and metal ions to 
determine the optimal biochemical conditions of the enzyme: 45 °C, pH 4 - 10, DŐ ?A? ?ScGalK 
demonstrated a high activity over a broad temperature and pH range, suggesting that the enzyme 
could be highly amenable to multi-enzyme systems. This was demonstrated by coupling the enzyme 
in one pot with BiGalHexNAcP for the synthesis of lacto-n-biose. Kinetic characterisation of the 
enzyme for its natural substrates afforded the kinetic constants for Gal: Km= 0.627 mM ± 0.061, 
Kcat/Km = 2.15 s¯¹ mM ¯¹ and ATP: Km= 0.035 mM ± 0.004, Kcat/Km = 38.90 s¯¹ mM ¯¹. ScGalK 
demonstrated a broad substrate specificity, turning over substrates such as GalN, Gal3D and GalNAc 
and also displayed activity towards Man and L-Ara, which has never been reported in a wild type 
bacterial GalK.  
 
4. Experimental 
4.1 General procedures 
All chemical reagents and solvents were purchased from commercial sources and used without 
further purification, unless stated otherwise. Samples for HRMS data analysis were submitted to the 
University of York Centre of Excellence in Mass Spectrometry (CoEMS) and analysed at room 
temperature on a Bruker Daltonics microTOF spectrometer. Reactions were analysed by silica gel 
thin-layer chromatography (TLC) by spotting 0.5 µL of each sample onto a TLC plate. A solvent 
system of nBuOH/AcOH/HA?O (2:1:1) was used and TLC plates were stained with p-anisaldehyde. ¹H 
and ¹³C NMR spectra were acquired on a Bruker 500-MR spectrometer at 500 MHz for ¹H and 125 
MHz for ¹³C. Multiplicities are given as singlet (s), doublet (d), doublet of doublets (dd), triplet of 
doublets (td), or multiplet (m). Resonances were assigned using HH-COSY and CHHMQC. All NMR 
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ĐŚĞŵŝĐĂůƐŚŝĨƚƐ  ?ɷ )ǁĞƌĞƌĞĐŽƌĚĞĚ ŝŶƉƉŵĂŶĚĐŽƵƉůŝŶŐ constants (J) are reported in Hz. TopSpin 
3.5pl7 and MestReNova were primarily used for processing the spectral data. 
 
4.2 Molecular cloning 
sco3136 (ScGalK) was amplified by PCR from Streptomyces coelicolor A3(2) J1929 [43] genomic DNA, 
ƵƐŝŶŐ ƉƌŝŵĞƌƐ d< ? ?  ? ? ?-CGCGCGGCAGCCATATGATGGGCGAGGCTGTCGCGGG AA- ? ? ) ĂŶĚ d< ? ?  ? ? ?-
GTTAGCAGCCGGATCCTCAGACCAGGCGCCGCGCCCCCG- ? ? ) ? dŚĞ WZ ƉƌŽĚƵĐƚ ǁĂƐ ƉƵƌŝĨŝĞĚ ďǇ ŐĞů
extraction using the illustra GFX PCR DNA and Gel Band Purification Kit (GE Healthcare), and cloned 
into NdeI and BamHI digested pET15b using the Quick-Fusion Cloning Kit (biotool). The resulting 
construct, SCO3136_pET15b was introduced into chemically competent E. coli , ?ɲĐĞůůƐďǇŚĞĂƚ
shock and the transformants were selected on lysogeny broth (LB) agar supplemented with 
ampicillin (100 ʅŐ ?ŵ> ) ? Plasmid DNA was isolated by using the QIAprep Spin Miniprep Kit (QIAGEN) 
and the SCO3136_pET15b construct was verified by DNA sequencing. 
 
4.3 Protein production and purification 
The SCO3136_pET15b plasmid was introduced into chemically competent E. coli BL21(DE3) cells by 
heat shock and selected on LB agar with ampicillin (100 µg/mL) at 37 °C for 16 h. Starter cultures 
were prepared by picking single clones into LB with ampicillin (100 µg/mL) and grown at 37 °C for 6 
h with shaking (180 rpm). 10 mL of starter culture was added to 1L of LB with ampicillin (100 µg/mL) 
and grown to an OD600 of 0.8 at 37 °C with shaking (180 rpm). Cultures were placed in an ice bath 
for 10 min. IPTG was added to a final concentration of 0.8 mM and the cultures were grown at 16 
°C for 22 h with shaking (180 rpm). Cells were harvested by centrifugation (6000 x g, 6 °C, 10 min) 
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and the pellet was resuspended in lysis buffer (30 mM Tris pH 8.0, 300 mM NaCl, 20 mM imidazole, 
1 mg/mL lysozyme, protease inhibitor, benzonase 1 U/mL). The cells were lysed by sonication on ice 
and the lysate was clarified by centrifugation (18 000 rpm, 4 °C, 45 min). The lysate was loaded onto 
a 5 mL HisTrap FF column (GE Healthcare) pre-equilibrated with binding buffer (30 mM Tris pH 8.0, 
300 mM NaCl, 20 mM imidazole). After washing the column with 20 CV of binding buffer, 
recombinant ScGalK with an N-ƚĞƌŵŝŶĂů,ŝƐA?-tag was eluted with elution buffer (30 mM Tris pH 8.0, 
300 mM NaCl, 250 mM imidazole). The protein was desalted and exchanged into 30 mM Tris pH 8.0 
ďƵĨĨĞƌƵƐŝŶŐ,ŝWƌĞƉ ? ? ? ? ? ?ĞƐĂůƚŝŶŐĐŽůƵŵŶ ?',ĞĂůƚŚĐĂƌĞ ) ?&ƵƌƚŚĞƌƉƵƌŝĨŝĐĂƚŝŽŶǁĂƐĐĂƌƌŝĞĚŽƵƚ
by using gel filtration chromatography (HiLoad 16/600 Superdex 200 pg) in 30 mM Tris pH 8.0 buffer. 
Typical yield was A? 33 mg/L culture. Purified ScGalK was stored at -80 °C in 10% (v/v) glycerol. 
 
4.4 Determination of substrate specificity 
Reactions were typically carried out in triplicate, on a 60 µL scale. Reactions were carried out in Tris 
buffer (60 ʅ> ? ? ? ? mM, pH  ? ? ? )Ăƚ  ? ?ര ?੔for 2 h (substrate 1) or 18 - 24 h (substrates 2 - 12). For 
substrate 1, specificity was determined in reactions containing monosaccharide (8 mM), ATP (10 
mM), MgCl2 (5 mM) and ScGalK (0.12 ʅŐ/µL). For substrates 2 - 12, specificity was determined in 
reactions containing monosaccharide (8 mM), ATP (10 mM), MgCl2 (5 mM) and ScGalK (0.5 ʅŐ ?A?> ) ?
The presence of the sugar-1-phosphate product was determined by HRMS and TLC. The conversion 
of monosaccharide substrates was determined by using the DNS assay, as described previously by 
[24]. Briefly, 50 µL of sample was added to 100 µL of DNS reagent. Samples were heated to 100 °C 
for 15 min, 4 °C for 1 min and 20 °C for 3 min in a PCR thermocycler, 15 µL of 40% (w/v) potassium 
tartrate solution was added to each sample and the absorbance at 575nm was recorded. Standard 
curves were prepared by using a series of sugar concentrations (0.5, 1, 2, 2.5, 3, 3.5, 4, 5, 6, 7, and 
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8 mM respectively) and ATP (10 mM) in Tris buffer (100 mM, pH 8.0) and submitting them to the 
DNS assay.  
 
4.5 Influence of temperature and pH  
For the temperature assay, reactions were prepared in triplicate on a 60 µL scale with substrate 1 
 ? ?ŵD ) ?dW ? ? ?ŵD ) ?DŐůA?(5 mM) and Tris buffer (100 mM, pH 8.0). Reactions were pre-incubated 
at 4, 16, 25, 30, 37, 45, 55 and 65 °C respectively for 5 min. ScGalK (7.2 µg) was added and the 
reactions were further incubated at the respective temperatures for 20 min. Substrate conversions 
were determined by the DNS assay.  
For the pH assay, reactions were prepared identically to the temperature assay with different 
buffers varying in pH (pH 2, 3 - glycine-HCl, pH 4, 5, 6 - sodium acetate, pH 7 - HEPES, pH 7.5, 8, 8.5 
- Tris-HCl and pH 9, 10 and 11 - glycine-NaOH. The reactions were pre-incubated at 37 °C for 5 min 
before the addition of ScGalK (7.2 µg). The reactions were further incubated at 37 °C for 20 min and 
the conversion of substrate 1 was determined via the DNS assay. 
For the metal ion screen, reactions were prepared in triplicate on a 60 µL scale with substrate 1 (8 
mM), ATP (10 mM), Tris buffer (100 mM, pH 8.0) and different metal ions (Mg2+, Ca2+, Zn 2+, Cu2+, 
Mn 2+ or Ni2+ at 5 mM) or EDTA (5 mM). The reactions were pre-incubated at 37 °C for 5 min before 
the addition of ScGalK (7.2 µg). The reactions were further incubated at 37 °C for 20 min and the 
conversion of substrate 1 was determined via the DNS assay. 
 
2.6 Determination of ScGalK kinetic parameters 
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Galactokinase activity was determined by coupling the formation of ADP to the reactions catalysed 
by pyruvate kinase and lactate dehydrogenase and the consumption of NADH, as previously 
described [36]. Reactions (150 µL) were assembled in microtitre plates containing 50 mM HEPES 
ďƵĨĨĞƌ  ?Ɖ,  ? ? ? ) ?  ? ? ? ŵD EĂů ?  ? ŵD DŐůA? ?1 mM phosphoenol pyruvate, 1 mM NADH, 7.5 U 
pyruvate kinase and 10 U lactate dehydrogenase. Reactions were supplemented with various 
concentrations of galactose (0.0625 - 4 mM) under saturating concentrations of ATP (10 mM), or 
with various concentrations of ATP (0.02  W 1.5 mM) under saturating concentrations of Gal (10 mM). 
All reaction components were added to the microtitre plate except for ScGalK, mixed and 
preincubated at 37 °C for 5 min. Reactions were initiated by the addition of ScGalK (161 nM) and 
the decrease in absorbance at 340 nm was measured every 30 s for 5 min. The initial velocity was 
calculated by determining the linear phase in the progress curve. Assays were assembled in 
triplicate. The data were fitted to the Michaelis-Menten equation and the apparent kinetic 
parameters were calculated by using GraphPad Prism v. 7.05. 
 
4.7 BiGalHexNAcP expression and purification 
The BiGalHexNAcP expression conditions were based on the procedure previously reported by Xi 
Chen and colleagues [31]. The BiGalHexNAcP_pET15b plasmid was introduced into chemically 
competent E. coli BL21(DE3) cells by heat shock and selected on LB agar with ampicillin (100 µg/mL) 
at 37 °C for 16 h. Starter cultures were prepared by picking single clones into LB with ampicillin (100 
µg/mL) and grown at 37 °C for 6 h with shaking (180 rpm). 10 mL of starter culture was added to 1L 
of LB with ampicillin (100 µg/mL) and grown to an OD600 of 0.8 at 37 °C with shaking (180 rpm). IPTG 
was added to a final concentration of 0.1 mM and the cultures were grown at 25 °C for 22 h with 
shaking (180 rpm). Cells were harvested by centrifugation (6000 x g, 6 °C, 10 min) and the pellet was 
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resuspended in lysis buffer (30 mM Tris pH 8.0, 300 mM NaCl, 20 mM imidazole, 1 mg/mL lysozyme, 
protease inhibitor, benzonase 1 U/mL). The cells were lysed by sonication on ice and the lysate was 
clarified by centrifugation (18 000 rpm, 4 °C, 45 min). The lysate was loaded onto a 5 mL HisTrap FF 
column (GE Healthcare) pre-equilibrated with binding buffer (30 mM Tris pH 8.0, 300 mM NaCl, 20 
mM imidazole). After washing the column with 20 CV of binding buffer, recombinant BiGalHexNAcP 
with an N-ƚĞƌŵŝŶĂů,ŝƐA?-tag was eluted with elution buffer (30 mM Tris pH 8.0, 300 mM NaCl, 250 
mM imidazole). Fractions containing BiGalHexNAcP were identified by 12% SDS-PAGE (Fig. S9) and 
pooled. The expected Mw of the protein was 86.5 kDa. The protein was dialysed in dialysis buffer 
(30 mM Tris pH 8.0) at 4 °C for 20 h, replacing with fresh dialysis buffer after 16 h. A yield of  ๝102 
mg L-1 of cell culture was retrieved. Purified BiGalHexNAcP was stored at -80 °C in 10% (v/v) glycerol. 
 
4.8 Large scale one-pot two enzyme (1P2E) synthesis of lacto-N-biose (17) 
 
The 1P2E synthesis of lacto-n-biose (17) was demonstrated on a 50 mg scale. The reaction was 
prepared by the addition of GlcNAc (8) (15 mM), Gal (1) (24 mM), ATP (15 mM), MgCl2 (20 mM) and 
Tris buffer (100 mM, pH 6.5) and adjusted to pH 6.5. ScGalK (45 mg) and BiGalHexNAcP (33 mg) 
were added and the reaction was incubated at 37 °C for 48 h. TLC was used to validate the depletion 
of GlcNAc (8) (Fig. S10). The enzyme was removed from the reaction mixture using a Vivaspin 
centrifugal concentrator (30 kDa MwCo). The reaction was diluted 10-fold in H2O and applied to a 
HiTrap Q HP anion exchange chromatography column (GE Healthcare) for the removal of the 
unreacted Gal-1P (2) and ADP. The column was washed with 5 CV of H2O. The disaccharide 
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containing flow-through and wash fractions were retained and lyophilised. The Gal-1P (2) and ADP 
were eluted from the column by using a 0-100 % gradient of 1 M NH4HCO3 and discarded. The 
disaccharide containing fraction was resolubilised in water and purified by gel filtration 
chromatography using a Bio-Gel P-2 polyacrylamide column (Bio-Rad) in H2O. Disaccharide 
containing fractions were pooled, lyophilised and validated by NMR (Fig. S4- S8). The product 17 
was obtĂŝŶĞĚĂƐĂ ? ? P ? ?ŵŝǆƚƵƌĞŽĨɲ PɴĂŶŽŵĞƌƐ ? 
 
 
Major = C-1D, Minor = C-1E 
E-D-Galactopyranosyl-(1 W3)-2-acetamido-2-deoxy-D-glucopyranose (GalE1 W3GlcNAc, 21). Yield, 
68%; white powder. ¹H NMR (500 MHz, D2O) G5.20 (d, J = 3.5 Hz, 0.6H, H-1 major), 77 (d, J = 8.5 
Hz, 0.4 H, H-1 minor), 4.49 (d, J = 7.7 Hz, 0.6H, H- ? ?major), 4.45 (d, J = 7.7 Hz, 0.4H, H-1 minor), 4.09 
(dd, 0.6 H, J = 10.6, 3.6 Hz, H-2 major), 3.98  W 3.77 (m, 7H, H-3, H- ? ? ?,-5, H-6, H- ? ?major; H-2, H-3, 
H- ? ? ?,-6, H- ? ?ŵŝŶŽƌ), 3.74 (m, J = 6.4, 3.2, 1.4 Hz, 1H, H- ? ?ŵĂũŽƌ ?ŵŝŶŽƌ), 3.67 (dt, J = 9.9, 3.4 Hz, 
1H, H- ? ?ŵĂũŽƌ ?ŵŝŶŽƌ), 3.64  W 3.50 (m, 2.4H, H- ? ? ?,-4 major; H- ? ? ?,-4, H-5 minor), 2.06 (s, 3H, 
NHCOC,Ј major & minor). 13C NMR (125 MHz, D2K )ɷ ? ? ? ?73 & 174.47 (NHCK,Ј major & minor), 
103.49 (C- ?ढ़ŵŝŶŽƌ), 103.37 (C- ?ढ़ŵĂũŽƌ), 94.65 (C-1 minor), 90.96 (C-1 major), 82.55, 80.11, 75.39, 
75.21, 75.16, 72.49, 72.45, 71.16, 70.66, 70.61, 68.64, 68.61, 68.48, 68.46, 60.93, 60.67, 60.51, 
59.34, 55.56, 52.82, 22.18 & 21.93 (NHCOC,Ј major & minor). HRMS (ESI) m/z calcd for CA?A?,A?A?EKA?A?
(M + H) 384.1500, found 384.1503 
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